litlas
Log inCreate account

Rohit Loomba

Active 2007–2026

484
Papers
96,844
Citations
153
h-index
455
i10-index

Citations

Citations per year for Rohit Loomba1944: 1 citations1965: 1 citations1966: 1 citations1983: 1 citations1996: 1 citations1997: 1 citations2000: 1 citations2001: 4 citations2003: 1 citations2005: 2 citations2007: 3 citations2008: 13 citations2009: 40 citations2010: 33 citations2011: 38 citations2012: 65 citations2013: 82 citations2014: 183 citations2015: 370 citations2016: 568 citations2017: 625 citations2018: 912 citations2019: 2,688 citations2020: 4,670 citations2021: 5,643 citations2022: 5,206 citations2023: 5,349 citations2024: 10,119 citations2025: 6,192 citations2026: 280 citations1945–1964: no citations, so these years are not shown1967–1982: no citations, so these years are not shown1984–1995: no citations, so these years are not shown1998–1999: no citations, so these years are not shown2002: no citations, so this year is not shown2004: no citations, so this year is not shown2006: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,826 citing papers, 20.1% of this breakdownChina: 5,918 citing papers, 17.4% of this breakdownUnited Kingdom: 1,781 citing papers, 5.2% of this breakdownItaly: 1,781 citing papers, 5.2% of this breakdownGermany: 1,371 citing papers, 4% of this breakdownJapan: 1,043 citing papers, 3.1% of this breakdownSpain: 1,006 citing papers, 3% of this breakdownFrance: 994 citing papers, 2.9% of this breakdownSouth Korea: 936 citing papers, 2.8% of this breakdownCanada: 822 citing papers, 2.4% of this breakdownAustralia: 777 citing papers, 2.3% of this breakdownIndia: 635 citing papers, 1.9% of this breakdown
0%20.1%Other 29.7%

Institutions

Fields

  • Medicine77.9%
  • Biochemistry, Genetics and Molecular Biology15.2%
  • Immunology and Microbiology1.9%
  • Environmental Science0.7%
  • Neuroscience0.7%
  • Nursing0.6%
  • Other3%

Topics

  • Liver Disease Diagnosis and Treatment20.5%
  • Liver Disease and Transplantation5%
  • Diet, Metabolism, and Disease4.2%
  • Gut microbiota and health3.1%
  • Alcohol Consumption and Health Effects2.7%
  • Diet and metabolism studies2.4%
  • Other62.1%

Coauthors

All papers

Open in search
  1. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    Authors: Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome, on behalf of the NAFLD Nomenclature consensus group - Hepatology 2023 cited by 2,904

  2. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

    Authors: Mary E. Rinella, Brent A. Neuschwander‐Tetri, Mohammad Shadab Siddiqui, Manal F. Abdelmalek, Stephen H. Caldwell, Diana Barb, David E. Kleiner, Rohit Loomba - Hepatology 2023 cited by 2,253

  3. A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis

    Authors: Stephen A. Harrison, Pierre Bédossa, Cynthia D. Guy, Jörn M. Schattenberg, Rohit Loomba, Rebecca Taub, Dominic Labriola, Sam E. Moussa, Guy Neff, Mary E. Rinella, Quentin M. Anstee, Manal F. Abdelmalek, Zobair M. Younossi, Seth J. Baum, Sven Francque, Michael Charlton, Philip N. Newsome, Nicolas Lanthier, Ingolf Schiefke, Alessandra Mangia, Juan M. Pericàs, Rashmee Patil, Arun J. Sanyal, Mazen Noureddin, Meena B. Bansal, Naim Alkhouri, Laurent Castéra, Madhavi Rudraraju, Vlad Ratziu - New England Journal of Medicine 2024 cited by 1,701

  4. MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease

    Authors: Mohammed Eslam, Arun J. Sanyal, Jacob George, Arun J. Sanyal, Brent A. Neuschwander‐Tetri, Claudio Tiribelli, David E. Kleiner, Elizabeth M. Brunt, Elisabetta Bugianesi, Hannele Yki‐Järvinen, Henning Grønbæk, Helena Cortez‐Pinto, Jacob George, Jian‐Gao Fan, Luca Valenti, Manal F. Abdelmalek, Manuel Romero‐Gómez, Mary E. Rinella, Marco Arrese, Mohammed Eslam, Pierre Bédossa, Philip N. Newsome, Quentin M. Anstee, Rajiv Jalan, Ramón Bataller, Rohit Loomba, Silvia Sookoian, Shiv Kumar Sarin, Stephen A. Harrison, Takumi Kawaguchi, Vincent Wai‐Sun Wong, Vlad Ratziu, Yusuf Yılmaz, Zobair M. Younossi - Gastroenterology 2020 cited by 3,274

  5. Mechanisms and disease consequences of nonalcoholic fatty liver disease

    Authors: Rohit Loomba, Scott L. Friedman, Gerald I. Shulman - Cell 2021 cited by 1,969

  6. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention

    Authors: Daniel Q. Huang, Hashem B. El‐Serag, Rohit Loomba - Nature Reviews Gastroenterology & Hepatology 2020 cited by 1,820

  7. A multisociety Delphi consensus statement on new fatty liver disease nomenclature

    Authors: Mary E. Rinella, Jeffrey V. Lazarus, Vlad Ratziu, Sven Francque, Arun J. Sanyal, Fasiha Kanwal, Diana Romero, Manal F. Abdelmalek, Quentin M. Anstee, Juan Pablo Arab, Marco Arrese, Ramón Bataller, Ulrich Beuers, Jérôme Boursier, Elisabetta Bugianesi, Christopher D. Byrne, Graciela Castro‐Narro, Abhijit Chowdhury, Helena Cortez‐Pinto, Donna R. Cryer, Kenneth Cusi, Mohamed El‐Kassas, Samuel Klein, Wayne Eskridge, Jian‐Gao Fan, Samer Gawrieh, Cynthia D. Guy, Stephen A. Harrison, Seung Up Kim, Bart G.P. Koot, Marko Korenjak, Kris V. Kowdley, Florence Lacaille, Rohit Loomba, Robert Mitchell-Thain, Timothy R. Morgan, Elisabeth E. Powell, Michael Roden, Manuel Romero‐Gómez, Marcelo Silva, Shivaram Prasad Singh, Silvia Sookoian, C Wendy Spearman, Dina Tiniakos, Luca Valenti, Miriam B. Vos, Vincent Wai‐Sun Wong, Stavra A. Xanthakos, Yusuf Yılmaz, Zobair M. Younossi, Ansley Hobbs, Marcela Villota‐Rivas, Philip N. Newsome - Annals of Hepatology 2023 cited by 2,698

  8. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease

    Authors: Chris Estes, Homie Razavi, Rohit Loomba, Zobair M. Younossi, Arun J. Sanyal - Hepatology 2017 cited by 2,393

  9. Prospective Study of Outcomes in Adults with Nonalcoholic Fatty Liver Disease

    Authors: Arun J. Sanyal, Mark L. Van Natta, Jeanne M. Clark, Brent A. Neuschwander‐Tetri, Anna‐Mae Diehl, Srinivasan Dasarathy, Rohit Loomba, Naga Chalasani, Kris V. Kowdley, Bilal Hameed, Laura Wilson, Katherine P. Yates, Patricia Belt, Mariana Lazo, David E. Kleiner, Cynthia Behling, James Tonascia - New England Journal of Medicine 2021 cited by 1,065

  10. Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis

    Authors: Rohit Loomba, Mark L. Hartman, Eric Lawitz, Raj Vuppalanchi, Jérôme Boursier, Elisabetta Bugianesi, Masato Yoneda, Cynthia Behling, Oscar W. Cummings, Yuanyuan Tang, Bram Brouwers, Deborah A. Robins, Amir Nikooie, Mathijs C. Bunck, Axel Haupt, Arun J. Sanyal - New England Journal of Medicine 2024 cited by 783

  11. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030

    Authors: Chris Estes, Quentin M. Anstee, M. Arias, Heike Bantel, Stefano Bellentani, Joan Caballería, Massimo Colombo, Antonio Craxı̀, Javier Crespo, Christopher P. Day, Yuichiro Eguchi, Andreas Geier, Loreta A. Kondili, Daniela C. Kroy, Jeffrey V. Lazarus, Rohit Loomba, Michael P. Manns, Giulio Marchesini, Atsushi Nakajima, Francesco Negro, Salvatore Petta, Vlad Ratziu, Manuel Romero‐Gómez, Arun J. Sanyal, Jörn M. Schattenberg, Frank Tacke, Junko Tanaka, Christian Trautwein, Lai Wei, Stefan Zeuzem, Homie Razavi - Journal of Hepatology 2018 cited by 2,008

  12. A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

    Authors: Sven Francque, Pierre Bédossa, Vlad Ratziu, Quentin M. Anstee, Elisabetta Bugianesi, Arun J. Sanyal, Rohit Loomba, Stephen A. Harrison, R. Balabanska, Lyudmila Mateva, Nicolas Lanthier, Naim Alkhouri, Christophe Moreno, Jörn M. Schattenberg, Diana Stefanova-Petrova, Luisa Vonghia, Régine Rouzier, Maéva Guillaume, Alexander Hodge, Manuel Romero‐Gómez, Philippe Huot-Marchand, Martine Baudin, Marie‐Paule Richard, Jean‐Louis Abitbol, Pierre Broqua, Jean‐Louis Junien, Manal F. Abdelmalek - New England Journal of Medicine 2021 cited by 721

  13. Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

    Authors: Parambir S. Dulai, Siddharth Singh, Janki Patel, Meera Soni, Larry J. Prokop, Zobair M. Younossi, Giada Sebastiani, Mattias Ekstedt, Hannes Hagström, Patrik Nasr, Per Stål, Vincent Wai‐Sun Wong, Stergios Kechagias, Rolf Hultcrantz, Rohit Loomba - Hepatology 2017 cited by 1,898

  14. Randomized, Controlled Trial of the FGF21 Analogue Pegozafermin in NASH

    Authors: Rohit Loomba, Arun J. Sanyal, Kris V. Kowdley, Deepak L. Bhatt, Naim Alkhouri, Juan P. Frías, Pierre Bédossa, Stephen A. Harrison, Donald J. Lazas, Robert J. Barish, Mildred D. Gottwald, Shibao Feng, Germaine D. Agollah, Cynthia L. Hartsfield, Hank Mansbach, Maya Margalit, Manal F. Abdelmalek - New England Journal of Medicine 2023 cited by 442

  15. Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

    Authors: Zobair M. Younossi, Vlad Ratziu, Rohit Loomba, Mary E. Rinella, Quentin M. Anstee, Zachary Goodman, Pierre Bédossa, Andreas Geier, Susanne Beckebaum, Philip N. Newsome, David Sheridan, Muhammad Y. Sheikh, James F. Trotter, W Knapple, Eric Lawitz, Manal F. Abdelmalek, Kris V. Kowdley, Aldo J. Montaño‐Loza, Jérôme Boursier, Philippe Mathurin, Elisabetta Bugianesi, G. Mazzella, Antonio Olveira, Helena Cortez‐Pinto, Isabel Graupera, David Orr, Lise Lotte Gluud, Jean‐François Dufour, David E. Shapiro, Jason Campagna, Luna Zaru, Leigh MacConell, Reshma Shringarpure, Stephen A. Harrison, Arun J. Sanyal, Manal F. Abdelmalek, Gary A. Abrams, Humberto Aguilar, Aijaz Ahmed, Elmar Aigner, Guruprasad P. Aithal, Aftab Ala, William Alazawi, Agustı́n Albillos, Michael Allison, Sfa Al-Shamma, Raúl J. Andrade, Pietro Andreoné, M. Angélico, Victor Ankoma‐Sey, Quentin M. Anstee, Rodolphe Anty, Víctor Araya, Juan Ignacio Arenas Ruiz, Perttu Arkkila, Marty Arora, Tarik Asselah, Jennifer Au, Oyekoya T. Ayonrinde, Robert J. Bailey, Maya Balakrishnan, Kiran Bambha, Meena B. Bansal, Sidney Barritt, John Bate, Jorge Beato, Susanne Beckebaum, Jaideep Behari, Pablo Bellot, Ziv Ben Ari, Michael Bennett, Marina Berenguer, Benedetta Terziroli Beretta‐Piccoli, Thomas Berg, Maurizio Bonacini, Lucía Bonet, Brian B. Borg, Marc Bourlière, Jérôme Boursier, William D. Bowman, David Bradley, Marija Branković, Marius Braun, Jean-Pierre Bronowicki, Savino Bruno, Elisabetta Bugianesi, Cindy X. Cai, Amy Calderon, José Luis Calleja Panero, Elizabeth J. Carey, Michal Carmiel, J.A. Carrión, Matthew C. Cave, Cristina Chagas, Tawfik N. Chami, Alan K. Chang, Allan Coates, Jeremy Cobbold, Charlote Costentin, Kathleen E. Corey and 288 more - The Lancet 2019 cited by 1,213

  16. The gut–liver axis and the intersection with the microbiome

    Authors: Anupriya Tripathi, Justine W. Debelius, David A. Brenner, Michael Karin, Rohit Loomba, Bernd Schnabl, Rob Knight - Nature Reviews Gastroenterology & Hepatology 2018 cited by 1,424

  17. Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial

    Authors: Rohit Loomba, Manal F. Abdelmalek, Matthew J. Armstrong, Maximilian Jara, Mette Skalshøi Kjær, Niels Krarup, Eric Lawitz, Vlad Ratziu, Arun J. Sanyal, Jörn M. Schattenberg, Philip N. Newsome - ˜The œLancet. Gastroenterology & hepatology 2023 cited by 472

  18. Global epidemiology of cirrhosis — aetiology, trends and predictions

    Authors: Daniel Q. Huang, Norah A. Terrault, Frank Tacke, Lise Lotte Gluud, Marco Arrese, Elisabetta Bugianesi, Rohit Loomba - Nature Reviews Gastroenterology & Hepatology 2023 cited by 766

  19. Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease

    Authors: Laurent Castéra, Mireen Friedrich‐Rust, Rohit Loomba - Gastroenterology 2019 cited by 1,471

  20. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

    Authors: Rohit Loomba, Victor Seguritan, Weizhong Li, Tao Long, Niels Klitgord, Archana Bhatt, Parambir S. Dulai, Cyrielle Caussy, Richele Bettencourt, Sarah K. Highlander, Marcus B. Jones, Claude B. Sirlin, Bernd Schnabl, Lauren Brinkac, Nicholas J. Schork, Chi‐Hua Chen, David A. Brenner, William Biggs, Shibu Yooseph, J. Craig Venter, Karen E. Nelson - Cell Metabolism 2017 cited by 1,097

  21. Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

    Authors: Brent A. Neuschwander‐Tetri, Rohit Loomba, Arun J. Sanyal, Joel E. Lavine, Mark L. Van Natta, Manal F. Abdelmalek, Naga Chalasani, Srinivasan Dasarathy, Anna Mae Diehl, Bilal Hameed, Kris V. Kowdley, Arthur J. McCullough, Norah A. Terrault, Jeanne M. Clark, James Tonascia, Elizabeth M. Brunt, David E. Kleiner, Edward Doo - The Lancet 2014 cited by 2,185

  22. Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies

    Authors: Siddharth Singh, Alina M. Allen, Zhen Wang, Larry J. Prokop, M. Hassan Murad, Rohit Loomba - Clinical Gastroenterology and Hepatology 2014 cited by 1,722

  23. Advancing the global public health agenda for NAFLD: a consensus statement

    Authors: Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castéra, Helena Cortez‐Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagström, Terry T.‐K. Huang, Mona Ismail, Achim Kautz, Shiv Kumar Sarin, Rohit Loomba, Veronica Miller, Philip N. Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary E. Rinella, Diana Romero, Manuel Romero‐Gómez, Jörn M. Schattenberg, Emmanuel Tsochatzis, Luca Valenti, Vincent Wai‐Sun Wong, Yusuf Yılmaz, Zobair M. Younossi, Shira Zelber‐Sagi, Fredrik Åberg, Leon A. Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Abdullatif Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramón Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourlière, Radan Brůha, Elisabetta Bugianesi, Patrizia Burra, Marı́a Buti, Christopher D. Byrne, José Luís Calleja, Patrizia Carrieri, Flloyd Carter, Marlén Ivón Castellanos Fernández, Gabriela Castillo-Lopez, Graciela Castro‐Narro, Henry Lik‐Yuen Chan, Wah‐Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen E. Corey, Antonio Craxı̀, Donna R. Cryer, Anuradha Supun Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Lédinghen, Stefano DelPrato, Sandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El‐Kassas, Osama Mohamed Elsanousi, Gamal Esmat, Jian‐Gao Fan, Nathalie J. Farpour‐Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino Alvani Gani, Lynn H. Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon‐Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch and 121 more - Nature Reviews Gastroenterology & Hepatology 2021 cited by 736

  24. Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer

    Authors: Daniel Q. Huang, Amit G. Singal, Yuko Kono, Darren Jun Hao Tan, Hashem B. El‐Serag, Rohit Loomba - Cell Metabolism 2022 cited by 509